| Mon, Nov 9, 2009 | | • | Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide
PR Newswire (Mon 9:00am)
| | Fri, Nov 6, 2009 | | • | SHIRE PLC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | • | [$$] Should You Buy It? Impax Labs
at RealMoney by TheStreet.com (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | • | SHIRE PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
EDGAR Online (Wed, Nov 4)
| | • | Shire Extends Agreement with Medidata Solutions for Trial Planning Products
Business Wire (Wed, Nov 4)
| | • | FDA Grants Priority Review for Shire's velaglucerase alfa for Type 1 Gaucher Disease
PR Newswire (Wed, Nov 4)
| | Mon, Nov 2, 2009 | | • | Award Winning Piper Jaffrey Analyst Sees Transkaryotic Therapeutics Acquisition Paying Off For Shire With Early 2010 Approval Of Velaglucerase
Wall Street Transcript (Mon, Nov 2)
| | • | CEO Interview, Cortex Pharmaceuticals, Inc. - Dr. Mark Varney
Wall Street Transcript (Mon, Nov 2)
| | • | New Shire Board Member
PR Newswire (Mon, Nov 2)
| | Sun, Nov 1, 2009 | | • | Shire plc Q3 2009 Earnings Call Transcript
at Seeking Alpha (Sun, Nov 1)
| | Fri, Oct 30, 2009 | | • | Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
PR Newswire (Fri, Oct 30)
| | • | SHIRE PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Fri, Oct 30)
| | • | Shire Continues to Deliver Excellent Growth From Core Products
PR Newswire (Fri, Oct 30)
| | Thu, Oct 29, 2009 | | • | New Data Show Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using the Oppositional Subscale of the Conners' ADHD Rating Scale
PR Newswire (Thu, Oct 29)
| | • | UPDATE - Amicus Q3 loss narrower than view; ends Shire pact
at Reuters (Thu, Oct 29)
| | • | Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30
PR Newswire (Thu, Oct 29)
| | Wed, Oct 28, 2009 | | • | SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
EDGAR Online (Wed, Oct 28)
| | • | SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
EDGAR Online (Wed, Oct 28)
| | • | Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease
PR Newswire (Wed, Oct 28)
| | Mon, Oct 26, 2009 | | • | London Markets: Standard Chartered, Shire help FTSE 100 to advance
at MarketWatch (Mon, Oct 26)
|
Add SHPGY News to My Yahoo!:
 
| |
|
0.05% Nasdaq 
Headlines
